The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” […]
Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies Read Post »
Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs. Here are some key
Innovative Approaches to Extend the Life of Drug Patents Read Post »
“Patents reward drugmakers for their inventions and, effectively, the large sums of money they invest in research and development. The
In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden.
Crucial Insights on Patent Litigation Strategies in Pharma Industry Read Post »
In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions
Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices Read Post »
Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate
The pharmaceutical industry in China is undergoing a significant transformation with the adoption of artificial intelligence (AI) technology. A recent
AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research Read Post »
A paper presented at the 2nd International Conference on Systems Medicine, AI, and Drug Repurposing proposes a novel approach to
Innovative Financing Models for Repurposing Generic Drugs Read Post »
A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP)
Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs Read Post »
Get fresh news and insights, drug patent expirations & more…
